FR2192815A2 - Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin - Google Patents

Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin

Info

Publication number
FR2192815A2
FR2192815A2 FR7226424A FR7226424A FR2192815A2 FR 2192815 A2 FR2192815 A2 FR 2192815A2 FR 7226424 A FR7226424 A FR 7226424A FR 7226424 A FR7226424 A FR 7226424A FR 2192815 A2 FR2192815 A2 FR 2192815A2
Authority
FR
France
Prior art keywords
compsns
contg
erosion
gastric mucosa
reserpine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7226424A
Other languages
French (fr)
Other versions
FR2192815B2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LYOCENTRE
Original Assignee
LYOCENTRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LYOCENTRE filed Critical LYOCENTRE
Priority to FR7226424A priority Critical patent/FR2192815A2/en
Publication of FR2192815A2 publication Critical patent/FR2192815A2/en
Application granted granted Critical
Publication of FR2192815B2 publication Critical patent/FR2192815B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In therapeutic compsns. contg. as active components (a) alumina of formula 2Al2O3.3H2O prepd. by hydrolysis of Al isopropoxide and (b) a cpd. provoking acid erosion of the gastric mucosa, the highly active 'transition' alumina reduces the ulcerogenic potential. Compsns. contain =50% alumina which may also replace some of the tablet additives esp. microcrystalline cellulose, Ca phosphate or talc.
FR7226424A 1972-07-21 1972-07-21 Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin Granted FR2192815A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7226424A FR2192815A2 (en) 1972-07-21 1972-07-21 Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7226424A FR2192815A2 (en) 1972-07-21 1972-07-21 Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin

Publications (2)

Publication Number Publication Date
FR2192815A2 true FR2192815A2 (en) 1974-02-15
FR2192815B2 FR2192815B2 (en) 1977-08-12

Family

ID=9102205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7226424A Granted FR2192815A2 (en) 1972-07-21 1972-07-21 Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin

Country Status (1)

Country Link
FR (1) FR2192815A2 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
(LE DICTIONNAIRE ALLEMAND "ROTE LISTE", 1971) *
REVUE "UNLISTED DRUGS", 1971, PAGE 17) *

Also Published As

Publication number Publication date
FR2192815B2 (en) 1977-08-12

Similar Documents

Publication Publication Date Title
AU467406B2 (en) NEW, l, 4-DIHYDROPYRIDINE CARBOXYLIC ACID COMPOUNDS, THEIR PRODUCTION, AND THEIR MEDICINAL USE
EP0130550A3 (en) Pharmaceutical compositions based on heparin and surfactants having an effect on the mucous membranes of the mouth, the nose and/or the throat
HU175933B (en) Process for producing 4-hydroxy-3,5-dialkyl-phenyl-propionic acid derivatives and pharmaceutical compositions containing ttem as active agents
FR2192815A2 (en) Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin
FR2279397A1 (en) PROCESS FOR THE PRODUCTION OF NEW 2-AMINO-1,4-DIHYDROPYRIDINES WITH CARBONYL FUNCTION AND MEDICINAL PRODUCT CONTAINING THESE COMPOUNDS
CA1016187A (en) PRODUCTION OF .alpha.-CHLOROCARBOXYLIC ACID CHLORIDES
JPS5257335A (en) Manufacture of novel, pharmacologically active polysacchiaride degrada tion products
IT973397B (en) PROCEDURE FOR THE DIRECT PRODUCTION OF 2.3 HYDROPERIMIDINS STARTING FROM 1.8 DINITRONAPHTHALINE
AU468532B2 (en) NEW l-IMIDAZOLYL-METHANEPHOSPHONIC ACID ESTERS, THEIR PRODUCTION, AND THEIR MEDICINAL USE
GB1248189A (en) Chewable tablets comprising an antibacterial agent
IT998352B (en) PROCEDURE FOR THE MANUFACTURING OF PACKAGING LOW D OXYGEN
TR18392A (en) PROCEDURES FOR THE PRODUCTION OF CITRIC ACID ESTERS, CITRIC ACID OR CITRIC ACID SALTS
DK13883A (en) TABLETS THAT DO NOT DAMAGE THE EATER
ES412097A1 (en) Saccharase inhibitors
ES386130A1 (en) Aminoethanesulfonic acid derivative
FR2077913A1 (en) Tablets contg gelatine capsules - for administration of liquid medicaments
GB1299037A (en) Dithiocarbamic acid esters
IT956869B (en) PROCEDURE FOR THE PREPARATION OF MAGNESIUM OXIDE STARTING FROM WATER SOLUTIONS CONTAINING MAGNESIUM IONS
SE431216B (en) PROCEDURE FOR THE PREPARATION OF 1N- (ALFA-HYDROXY-OMEGA-AMINO-ALKANOYL) -6 721N-METHYL-3 721, 4 721-DIDEOXICANAMYCINE B OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
CA946404A (en) Production of anhydrous 1,4-dioxane
GB1287433A (en) Pharmaceutical compositions
CA996575A (en) Isolation of a medical drug from an aqueous solution
ES383340A1 (en) P-(acetoacetamidoalkyl)benzenesulfonamide derivatives
FR2177628A1 (en) Peptide extracted from tekra flowers - for treating varicose veins and haemorrhoids
FR2138492A1 (en) Basic aluminium salts of gum xanthane - pharmaceutical gelling agents